Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Core Scientific (CORZ) EBIT Margin: 2021-2025

Historic EBIT Margin for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -70.81%.

  • Core Scientific's EBIT Margin fell 2758.00% to -70.81% in Q3 2025 from the same period last year, while for Sep 2025 it was -49.70%, marking a year-over-year decrease of 5410.00%. This contributed to the annual value of -3.76% for FY2024, which is 554.00% down from last year.
  • Per Core Scientific's latest filing, its EBIT Margin stood at -70.81% for Q3 2025, which was down 111.81% from -33.43% recorded in Q2 2025.
  • Core Scientific's EBIT Margin's 5-year high stood at 33.85% during Q4 2021, with a 5-year trough of -637.54% in Q2 2022.
  • In the last 3 years, Core Scientific's EBIT Margin had a median value of -10.67% in 2023 and averaged -18.33%.
  • In the last 5 years, Core Scientific's EBIT Margin plummeted by 65,816bps in 2022 and then soared by 64,500bps in 2023.
  • Quarterly analysis of 5 years shows Core Scientific's EBIT Margin stood at 33.85% in 2021, then plummeted by 55,845bps to -524.60% in 2022, then skyrocketed by 52,737bps to 2.77% in 2023, then plummeted by 4,468bps to -41.91% in 2024, then plummeted by 2,758bps to -70.81% in 2025.
  • Its EBIT Margin stands at -70.81% for Q3 2025, versus -33.43% for Q2 2025 and -53.56% for Q1 2025.